Franklin Templeton Inc. (BEN) Stock Price & Analysis
Franklin Templeton Inc. (BEN) closed at USD 31.52 on Thursday, October 22, 2026, down 0.51% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 31.68; the Oct 22, 2026 session ranged USD 31.17–31.93 on volume of 2,716,478 shares. Market capitalization is $16.01B, with a 52-week range of USD 21.11–36.28 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:57 UTC.
Also available as compact Markdown for AI agents: nexqual.com/BEN.md
Key facts (BEN)
- Last four reported quarters (through Jun 30, 2026): revenue $9.32B, net income $813M (8.7% margin) (SEC filings).
- Valuation: P/E 19.7x (avg 19.5x at the last 3 fiscal year-ends), EV/EBITDA 14.3x, net cash $1.36B.
- Earnings quality: non-operating income $617M vs operating income $906M over the last four quarters; P/E excluding non-operating income ≈45.5x (estimate: non-operating income taxed at the company's 25.3% effective rate).
- 1 of 80 tracked superinvestors hold BEN (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Analysts: Hold (mean 2.92 on a 1–5 scale) (13 analysts), mean target USD 35.46 (range 26–40).
- Total return with dividends: 1Y +45.9% vs S&P 500 +14.9%; 5Y +31.6% vs S&P 500 +80.3%.
- Next earnings: 2026-11-06, EPS estimate USD 0.77, revenue estimate $2.14B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (BEN)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $8.43B | $8.28B | $7.85B | $8.48B | $8.77B | $9.32B |
| Operating income | $1.88B | $1.77B | $1.10B | $408M | $604M | $906M |
| Net income | $1.83B | $1.29B | $883M | $465M | $525M | $813M |
| EPS (diluted) | $3.57 | $2.53 | $1.72 | $0.85 | $0.91 | — |
| Free cash flow | $1.17B | $1.87B | $940M | $794M | $912M | — |
| Operating margin | 22.3% | 21.4% | 14.0% | 4.8% | 6.9% | 9.7% |
| Net margin | 21.7% | 15.6% | 11.2% | 5.5% | 6.0% | 8.7% |
| Revenue growth | +51.4% | -1.8% | -5.1% | +8.0% | +3.5% | — |
| Cash + short-term investments | $4.65B | $4.78B | $4.40B | $4.41B | $3.57B | — |
| Total debt | $3.40B | $3.38B | $3.05B | $2.78B | $2.36B | — |
Fiscal years end Sep. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (BEN)
P/E 19.7x · P/E ex non-operating (est.) ≈45.5x · P/S 1.7x · EV/EBITDA 14.3x · EV/Sales 1.6x · P/B 1.4x · Earnings yield 5.08% · Dividend yield (paid, TTM) 4.33% · Buyback yield (TTM) 3.20% · Net cash $1.36B · EV $14.7B
P/E at fiscal year-ends: Sep 2025 22.8x, Sep 2024 22.1x, Sep 2023 13.7x.
Superinvestors (SEC 13F-HR, Q2 2026) (BEN)
1 of 80 tracked investors hold BEN. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Polen Capital | Polen Capital Management | <0.01% | $458K | New position |
Analysts (BEN)
Consensus Hold (mean 2.92 on a 1–5 scale), 13 analysts; mean target USD 35.46 (low 26, high 40).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-14 | Barclays | Target lowered | Equal-Weight | $36 → $34 |
| 2026-10-12 | JP Morgan | Target raised | Neutral | $34 → $35 |
| 2026-10-12 | TD Cowen | Target lowered | Buy | $40 → $38 |
| 2026-10-09 | Evercore ISI Group | Target lowered | Underperform | $36 → $35 |
| 2026-09-25 | Morgan Stanley | Target raised | Equal-Weight | $34 → $35 |
| 2026-08-03 | Evercore ISI Group | Target raised | Underperform | $35 → $36 |
| 2026-08-03 | Barclays | Target raised | Equal-Weight | $34 → $36 |
| 2026-07-14 | Barclays | Target raised | Equal-Weight | $31 → $34 |
| 2026-07-10 | Evercore ISI Group | Target raised | Underperform | $32 → $35 |
| 2026-06-26 | Morgan Stanley | Target raised | Equal-Weight | $31 → $34 |
Total return (dividends reinvested) (BEN)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +45.9% | +31.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +46.1% | +5.6% |
| Volatility (annualized) | 27.6% | 29.8% |
| Max drawdown | -19.2% (Feb 2026→Mar 2026) | -42.0% (Nov 2021→Mar 2025) |
BEN revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Investment management fees | $1.87B | 79.1% | +13.7% |
| Sales and distribution fees | $404.5M | 17.2% | +14.9% |
| Shareholder servicing fees | $74.3M | 3.2% | +24.0% |
| Other | $13.4M | 0.6% | +17.5% |
| Total revenue | $2.36B | 100% | — |
BEN revenue by region (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| United States | $1.71B | 72.5% | +10.1% |
| Luxembourg | $395.4M | 16.8% | +28.0% |
| Asia-Pacific | $103.4M | 4.4% | +25.5% |
| Europe, Middle East and Africa, Excluding Luxembourg | $75.5M | 3.2% | +25.8% |
| Americas Excluding United States | $73.5M | 3.1% | +24.8% |
| Total revenue | $2.36B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
BEN suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | ClearBridge Investments | “We offer our services and products under our various distinct brand names, including, but not limited to, Alcentra®, Apera®, Benefit Street Partners®, Brandywine Global Investment Management®, Canvas®, Clarion Partners®, ClearBridge Investments®, Fiduciary Trust International™, Franklin®, Franklin Mutual Series®, K2®, Legg Mason®, Lexington Partners®, O'Shaughnessy®, Putnam®, Royce®, Templeton® and Western Asset M…” |
| Partner | GREAT-WEST LIFECO INC. (GWLIF) | “We will pay up to $375.0 million related to our acquisition of Putnam between the third and seventh anniversaries of the closing date related to revenue growth targets from the strategic partnership with Great-West Lifeco, Inc. which will be recognized in operating income.” |
Quoted from the company's 10-K filed Nov 10, 2025.
BEN analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.77 | $0.76 | +1.6% | $2.14B | 10 |
| Next quarter (ends Dec 2026) | $0.73 | $0.74 | -1.6% | $2.15B | 7 |
| Current fiscal year (ends Sep 2026) | $2.90 | $2.82 | +3.0% | $8.81B | 11 |
| Next fiscal year (ends Sep 2027) | $3.16 | $3.10 | +1.8% | $8.89B | 12 |
BEN options: expected move
Options price a move of about ±7.3% (±$2.30) by Nov 20, 2026, which includes earnings on Nov 6, 2026. Over the last 8 reports the stock moved ±4.4% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 31.8% | ±7.3% |
| Dec 18, 2026 | 56 | 30.8% | ±9.8% |
| Jan 15, 2027 | 84 | 27.3% | ±10.7% |
| Apr 16, 2027 | 175 | 30.0% | ±16.7% |
30-day implied volatility 30.3% vs 20.2% realized over the last 30 trading days. Put/call ratio (volume) 0.67. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:57 UTC)
| Price | USD 31.52 |
|---|---|
| Change | ▼ 0.51% (down) |
| Previous Close | USD 31.68 |
| Open | USD 31.23 |
| Day Range | USD 31.17 – 31.93 |
| 52-Week Range | USD 21.11 – 36.28 |
| Volume | 2,716,478 shares |
| Market Cap | $16.01B |
| Exchange | NYQ |
Technical Analysis (BEN)
Nexqual's technical model rates BEN "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 09:57 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 40.79 (neutral) |
| vs SMA50 | Below (USD 33.07) |
| MACD | -0.53 (negative) |
Analyst Ratings (BEN)
Wall Street analysts rate BEN "Hold" based on 13 analysts, with a mean price target of USD 35.46 (range USD 26–40), per Nexqual as of October 23, 2026 at 09:57 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 13 |
| Mean Target | USD 35.46 |
| High Target | USD 40 |
| Low Target | USD 26 |
| Buy / Hold / Sell | 4 / 7 / 2 |
Earnings (BEN)
| Next Earnings Date | 2026-11-06 |
|---|---|
| EPS Estimate | USD 0.77 |
| Revenue Estimate | $2.14B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.72 vs est 0.66 ▲ beat |
| 2026-03-31 | USD 0.71 vs est 0.55 ▲ beat |
| 2025-12-31 | USD 0.7 vs est 0.55 ▲ beat |
| 2025-09-30 | USD 0.67 vs est 0.59 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:57 UTC.
Financials & Fundamentals (BEN)
| Total Revenue | $9.32B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +14.30% |
| Gross Margin | +37.71% |
| Operating Margin | +12.98% |
| Profit Margin | +8.72% |
| ROE | +7.89% |
| Debt / Equity | 0.25 |
| Current Ratio | 5.49 |
| Total Cash | $2.67B |
| Total Debt | $3.57B |
| Free Cash Flow (fiscal year ended Sep 2025, SEC 10-K) | $911.60M (10.4% of revenue) |
Source: Nexqual, October 23, 2026 at 09:57 UTC.
Financial Health Score (BEN)
Nexqual rates Franklin Templeton Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:57 UTC.
| Growth | Mixed — Revenue +3.5% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 38%, operating 13% (last 12 months) |
| Balance Sheet | Strong — $3.76B cash and investments vs $2.40B debt (Jun 2026, SEC), net cash |
| Cash Flow | Solid — FCF $912M (FY ended Sep 2025, 10-K), 10% margin |
| Efficiency | Mixed — ROE 8%, ROA 2.6% |
Ownership (BEN)
| Insider Ownership | +48.65% |
|---|---|
| Institutional Ownership | +50.07% |
| Shares Outstanding | 508.08M |
| Float | 290.14M |
| Short % of Float | +4.76% |
Source: Nexqual, October 23, 2026 at 09:57 UTC.
Leadership (BEN)
Franklin Templeton Inc. is led by Jennifer M. Johnson, CEO & Non-Independent Director, per Nexqual as of October 23, 2026 at 09:57 UTC.
| CEO & Non-Independent Director | Jennifer M. Johnson |
|---|---|
| Executive Chairman of the Board & Non-Independent Director | Gregory Eugene Johnson |
| Co-President, CFO & COO | Matthew Nicholls |
| Co-President & Head of Public Market Investments | Terrence James Murphy |
| Co-President & Chief Commercial Officer | Daniel Ernesto Gamba |
Major Backers & Investors (BEN)
Notable institutional backers of Franklin Templeton Inc. include Power Corp of Canada, Invesco, Goldman Sachs, according to Nexqual as of October 23, 2026 at 09:57 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Power Corp of Canada | 4.99% |
| Invesco | 2.38% |
| Goldman Sachs | 1.43% |
| Azora Capital Lp | 1.36% |
| ProShares Trust-ProShares S&P 500 Dividend Aristocrats ETF | 1% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 6.66% |
| BlackRock | 5.69% |
| State Street | 3.88% |
| Dimensional Fund Advisors | 2.01% |
| Geode Capital | 1.56% |
Source: Nexqual, October 23, 2026 at 09:57 UTC.
From Franklin Templeton Inc.'s Latest SEC 10-K Filing (filed 2025-11-10)
Key Strengths & Strategy (as disclosed to the SEC)
- In Luxembourg, the Commission de Surveillance du Secteur Financier ("CSSF") regulates our substantial activities in Luxembourg, including our subsidiary Franklin Templeton International Services S.à r.l. ("FTIS Lux").
Partnerships
- Our global distribution group is responsible for sales, marketing and business development and maintains a regional distribution model, with regional teams responsible for driving initiatives in collaboration with global teams.
- For over 75 years, we have been committed to providing clients with exceptional investment management services and have developed a globally diversified business, including through strategic acquisitions.
Legal & Regulatory Risks (Item 1A, quoted)
- We may be adversely affected as a result of new or revised legislation or regulations or by changes in the interpretation of existing laws and regulations, in the U.S. and other jurisdictions.
- Failure to comply with the laws, rules or regulations in any of the jurisdictions in which we operate could result in substantial harm to our reputation and results of operations.
- Changes in tax laws or exposure to additional income tax liabilities could have a material impact on our financial condition, revenues and income.
- Regulatory and governmental examinations and/or investigations, litigation and the legal risks associated with our business, could adversely impact our AUM, increase costs and negatively impact our profitability and/or our future financial results.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CRBG | Corebridge Financial Inc. | USD 35.59 | ▲ 0.82% |
| OWL | Blue Owl Capital Inc. | USD 9.71 | ▲ 5.89% |
| EQH | Equitable Holdings, Inc. | USD 55.04 | ▲ 1.23% |
| PHYS | "Sprott Physical Gold Trust" | USD 30.39 | ▼ 2.72% |
| PS | Pershing Square Inc. | USD 45.04 | ▼ 3.72% |
| TPG | TPG Inc. | USD 46.17 | ▲ 4.74% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:57 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt